ArticleFrontiers in medicine2026
Case Report: Secondary syphilis with pulmonary involvement mimicking eosinophilic granulomatosis with polyangiitis - targeted next-generation sequencing as an adjunct in resolving an atypical non-exanthematous presentation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global resurgence of syphilis poses growing challenges for clinical diagnosis, particularly when atypical presentations without classic mucocutaneous lesions mimic systemic autoimmune diseases. Pulmonary involvement in secondary syphilis is rare and frequently misdiagnosed, leading to inappropriate immunosuppressive therapy. Case presentation: A 24-year-old male presented with one month of inflammatory back pain and two weeks of cough, purulent sputum, and intermittent low-grade fever. He initially denied high-risk sexual exposure. Physical examination revealed no rash, chancre, or lymphadenopathy. Laboratory workup showed marked eosinophilia (15.70%), elevated C-reactive protein, and immunoglobulin E (1,290 IU/mL). Chest computed tomography demonstrated bilateral patchy infiltrates and multiple small upper-lobe nodules. While this presentation suggested eosinophilic granulomatosis with polyangiitis (EGPA), unexpected positive syphilis serology (rapid plasma reagin 1:128) redirected the diagnostic workup. Upon further confidential questioning, the patient acknowledged high-risk sexual exposures. Bronchoalveolar lavage fluid targeted next-generation sequencing (tNGS) detected a high load of Treponema pallidum (11,732 reads) alongside co-infecting respiratory pathogens. EGPA was rendered highly unlikely by complete clinical and radiological resolution following antimicrobial therapy alone, without corticosteroids. Conclusion: This case illustrates that non-rash secondary pulmonary syphilis can closely mimic EGPA, and that tNGS provides a valuable adjunctive tool for resolving such diagnostic challenges, thereby preventing potentially harmful immunosuppressive treatment. As syphilis continues to re-emerge globally, clinicians should maintain a high index of suspicion for syphilitic pulmonary involvement in patients with unexplained eosinophilia and pulmonary infiltrates, even in the absence of dermatological manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.